Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system.
about
Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.Granulated colloidal silicon dioxide-based self-microemulsifying tablets, as a versatile approach in enhancement of solubility and therapeutic potential of anti-diabetic agent: formulation design and in vitro/in vivo evaluation.Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluationRecent approaches of lipid-based delivery system for lymphatic targeting via oral route.Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations.Gold Nanoparticle-Quantum Dot Fluorescent Nanohybrid: Application for Localized Surface Plasmon Resonance-induced Molecular Beacon Ultrasensitive DNA Detection.Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique.Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.Preparation, characterization and in vitro evaluation of microemulsion of raloxifene hydrochloride.
P2860
Q36148640-192E80EE-0E2C-46D6-A32B-5751662750FBQ36301891-DA0B31ED-AF09-44E9-B219-08722DAFD54CQ36870135-E5B2C8BE-6521-4CF4-8FD3-2B3852668D4EQ37066550-F70DBCEF-DD1F-429C-B7CA-05DA3C2412AAQ37280515-2309A0D2-7CF5-4E80-8CDE-249999E062B3Q37446591-F5F0089A-9496-4479-80AA-BDF8196DB082Q38242314-5096FAEC-30D9-4857-B12F-3EA42A78EB02Q41545455-49177406-5A4D-4064-B481-BF3E77555D22Q41988327-9A98B738-FCEA-43AD-A71D-ACC5B65A584AQ42363250-5E98AAC8-EFE1-4EF0-8C5C-2D572C1CD9DBQ46722927-B8FCA42B-4C29-4B15-A73D-F8B0C90D6D0FQ47784707-14582999-EFA8-465A-9832-5B899CBA4197Q50881321-BEE20270-BFC8-425A-AC68-19F7C13A7FA8
P2860
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Formulation and characterizati ...... lsifying drug delivery system.
@ast
Formulation and characterizati ...... lsifying drug delivery system.
@en
type
label
Formulation and characterizati ...... lsifying drug delivery system.
@ast
Formulation and characterizati ...... lsifying drug delivery system.
@en
prefLabel
Formulation and characterizati ...... lsifying drug delivery system.
@ast
Formulation and characterizati ...... lsifying drug delivery system.
@en
P2093
P2860
P356
P1476
Formulation and characterizati ...... ulsifying drug delivery system
@en
P2093
Divyakant Patel
Jitesh Nangesh
Mayur Parmar
P2860
P304
P356
10.4103/0975-7406.84463
P577
2011-07-01T00:00:00Z